Trial intelligence / Profile preview

PK and Safety of VML-0203 (Estradiol Cream) in Post-menopausal Women

NCT03556800Phase 1Unknown

Sponsor
Viramal
Start
May 2018
Primary completion
Jun 2022
Countries
1
01

Overview

Phase 1, randomised, open-label trial of estradiol topical in menopause (4 arms), sponsored by Viramal. Primary endpoint: Bioavailability of estradiol and estrone at 4 weeks. Status: unknown.

02

Drugs

estradiol topical
03

Conditions

menopause

Beyond the preview

Go deeper on NCT03556800.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03556800.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call